The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop

被引:240
|
作者
Lu, Xiongbin [1 ]
Ma, Ou
Nguyen, Thuy-Ai
Joness, Stephen N.
Oren, Moshe
Donehower, Lawrence A.
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[4] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA
[5] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[6] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.ccr.2007.08.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is a transcription factor that responds to cellular stresses by initiating cell cycle arrest or apoptosis. One transcriptional target of p53 is Mdm2, an E3 ubiquitin ligase that interacts with p53 to promote its proteasomal degradation in a negative feedback regulatory loop. Here we show that the wild-type p53-induced phosphatase 1 (Wipl), or PPM1 D, downregulates p53 protein levels by stabilizing Mdm2 and facilitating its access to p53. Wipl interacts with and dephosphorylates Mdm2 at serine 395, a site phosphorylated by the ATM kinase. Dephosphorylated Mdm2 has increased stability and affinity for p53, facilitating p53 ubiquitination and degradation. Thus, Wipl acts as a gatekeeper in the Mdm2-p53 regulatory loop by stabilizing Mdm2 and promoting Mdm2-mediated proteolysis of p53.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 50 条
  • [21] The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene
    Choi, J
    Appella, E
    Donehower, LA
    GENOMICS, 2000, 64 (03) : 298 - 306
  • [22] p21WAF1/CIP1 promotes p53 protein degradation by facilitating p53-Wip1 and p53-Mdm2 interaction
    Lee, Jihyun
    Kim, Jongdoo
    Kim, Eun Mi
    Kim, Ukjin
    Kang, A-Ram
    Park, Jong Kuk
    Um, Hong-Duck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 543 : 23 - 28
  • [23] Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
    Bar-Or, RL
    Maya, R
    Segel, LA
    Alon, U
    Levine, AJ
    Oren, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) : 11250 - 11255
  • [24] Activating p53 through MDM2 and WIP1 inhibition effectively inhibits tumors in liver adenocarcinoma
    Chen, Chiao-Ping
    Yeh, Chun-Nan
    Pan, Yi-Ru
    Hsiao, Yu-Tien
    Lo, Chih-Hong
    Jhuang, Cai-Jhen
    Wu, Chiao-En
    CANCER RESEARCH, 2022, 82 (12)
  • [25] Relevance of the p53-MDM2 axis to aging
    Wu, Danyi
    Prives, Carol
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (01): : 169 - 179
  • [26] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [27] p53-Mdm2 - the affair that never ends
    Alarcon-Vargas, D
    Ronai, Z
    CARCINOGENESIS, 2002, 23 (04) : 541 - 547
  • [28] Dynamics in the p53-Mdm2 ubiquitination pathway
    Brooks, CL
    Gu, W
    CELL CYCLE, 2004, 3 (07) : 895 - 899
  • [29] The p53-MDM2 interaction in adult medulloblastomas
    Giordana, MT
    Schiffer, P
    Boghi, A
    Pradotto, L
    Morra, I
    Mauro, A
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 447 - 447
  • [30] The p53-Mdm2 module and the ubiquitin system
    Michael, D
    Oren, M
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) : 49 - 58